Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Perceived dignity is an unrecognized source of emotional distress in patients with rheumatic diseases: Results from the validation of the Mexican version of the Patient Dignity Inventory.
Pascual-Ramos V, Contreras-Yáñez I, Cuevas-Montoya M, Guaracha-Basáñez GA, García-Alanís CM, Rodríguez-Mayoral O, Chochinov HM. Pascual-Ramos V, et al. PLoS One. 2023 Aug 4;18(8):e0289315. doi: 10.1371/journal.pone.0289315. eCollection 2023. PLoS One. 2023. PMID: 37540659 Free PMC article.
The method used to set the pass mark in an objective structured clinical examination defines the performance of candidates for certification as rheumatologists.
Pascual-Ramos V, Guilaisne Bernard-Medina A, Flores-Alvarado DE, Portela-Hernández M, Maldonado-Velázquez MDR, Jara-Quezada LJ, Amezcua-Guerra LM, Rubio-Judith López-Zepeda NE, Álvarez-Hernandez E, Saavedra MÁ, Arce-Salinas CA; Consejo Mexicano de Reumatología (CMR). Pascual-Ramos V, et al. Reumatol Clin (Engl Ed). 2018 May-Jun;14(3):137-141. doi: 10.1016/j.reuma.2016.11.007. Epub 2017 Feb 1. Reumatol Clin (Engl Ed). 2018. PMID: 28161396 Free article. English, Spanish.
A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone.
Kremer JM, Cohen S, Wilkinson BE, Connell CA, French JL, Gomez-Reino J, Gruben D, Kanik KS, Krishnaswami S, Pascual-Ramos V, Wallenstein G, Zwillich SH. Kremer JM, et al. Arthritis Rheum. 2012 Apr;64(4):970-81. doi: 10.1002/art.33419. Epub 2011 Oct 17. Arthritis Rheum. 2012. PMID: 22006202 Free article. Clinical Trial.
Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four-Month, Phase III Study.
van der Heijde D, Strand V, Tanaka Y, Keystone E, Kremer J, Zerbini CAF, Cardiel MH, Cohen S, Nash P, Song YW, Tegzová D, Gruben D, Wallenstein G, Connell CA, Fleischmann R; ORAL Scan Investigators. van der Heijde D, et al. Arthritis Rheumatol. 2019 Jun;71(6):878-891. doi: 10.1002/art.40803. Epub 2019 Apr 24. Arthritis Rheumatol. 2019. PMID: 30666826 Free PMC article. Clinical Trial.
Anti-malarials exert a protective effect while Mestizo patients are at increased risk of developing SLE renal disease: data from a Latin-American cohort.
Pons-Estel GJ, Alarcón GS, Hachuel L, Boggio G, Wojdyla D, Pascual-Ramos V, Soriano ER, Saurit V, Cavalcanti FS, Guzman RA, Guibert-Toledano M, Sauza Del Pozo MJ, Amigo MC, Alva M, Esteva-Spinetti MH, Pons-Estel BA; GLADEL. Pons-Estel GJ, et al. Rheumatology (Oxford). 2012 Jul;51(7):1293-8. doi: 10.1093/rheumatology/ker514. Epub 2012 Mar 2. Rheumatology (Oxford). 2012. PMID: 22389125 Free PMC article.
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL, Germino R, Menon S, Sun Y, Wang C, Shapiro AB, Kanik KS, Connell CA; ORAL Surveillance Investigators. Ytterberg SR, et al. N Engl J Med. 2022 Jan 27;386(4):316-326. doi: 10.1056/NEJMoa2109927. N Engl J Med. 2022. PMID: 35081280 Clinical Trial.
Lupus in Latin-American patients: lessons from the GLADEL cohort.
Pons-Estel GJ, Catoggio LJ, Cardiel MH, Bonfa E, Caeiro F, Sato E, Massardo L, Molina-Restrepo JF, Toledano MG, Barile-Fabris LA, Amigo MC, Acevedo-Vásquez EM, Abadi I, Wojdyla D, Alarcón-Riquelme ME, Alarcón GS, Pons-Estel BA; GLADEL. Pons-Estel GJ, et al. Lupus. 2015 May;24(6):536-45. doi: 10.1177/0961203314567753. Epub 2015 Feb 18. Lupus. 2015. PMID: 25697768 Review.
Primary cardiac disease in systemic lupus erythematosus patients: protective and risk factors--data from a multi-ethnic Latin American cohort.
García MA, Alarcón GS, Boggio G, Hachuel L, Marcos AI, Marcos JC, Gentiletti S, Caeiro F, Sato EI, Borba EF, Brenol JC, Massardo L, Molina-Restrepo JF, Vásquez G, Guibert-Toledano M, Barile-Fabris L, Amigo MC, Huerta-Yáñez GF, Cucho-Venegas JM, Chacón-Diaz R, Pons-Estel BA; Grupo Latino Americano de Estudio del Lupus Eritematoso (GLADEL). García MA, et al. Rheumatology (Oxford). 2014 Aug;53(8):1431-8. doi: 10.1093/rheumatology/keu011. Epub 2014 Mar 14. Rheumatology (Oxford). 2014. PMID: 24633413
Mestizos with systemic lupus erythematosus develop renal disease early while antimalarials retard its appearance: data from a Latin American cohort.
Pons-Estel GJ, Alarcón GS, Burgos PI, Hachuel L, Boggio G, Wojdyla D, Nieto R, Alvarellos A, Catoggio LJ, Guibert-Toledano M, Sarano J, Massardo L, Vásquez GM, Iglesias-Gamarra A, Lavras Costallat LT, Da Silva NA, Alfaro JL, Abadi I, Segami MI, Huerta G, Cardiel MH, Pons-Estel BA; Grupo Latino Americano de Estudio de Lupus (GLADEL). Pons-Estel GJ, et al. Lupus. 2013 Aug;22(9):899-907. doi: 10.1177/0961203313496339. Epub 2013 Jul 15. Lupus. 2013. PMID: 23857989 Free PMC article.
Childhood systemic lupus erythematosus in Latin America. The GLADEL experience in 230 children.
Ramírez Gómez LA, Uribe Uribe O, Osio Uribe O, Grisales Romero H, Cardiel MH, Wojdyla D, Pons-Estel BA; Grupo Latinoamericano de Estudio del Lupus (GLADEL); Catoggio LJ, Soriano ER, Imamura PM, Manni JA, Grimaudo S, Sarano J, Maldonado-Cocco JA, Arriola MS, Gómez G, García MA, Marcos AI, Marcos JC, Scherbarth HR, Marino PC, Motta EL, Drenkard C, Gamron S, Buliubasich S, Onetti CM, Caeiro F, Alvarellos A, Saurit V, Gentiletti S, Quagliatto N, Gentiletti AA, Machado D, Abdala M, Palatnik S, Berbotto GA, Battagliotti CA, Sato E, Sella EM, Souza AS, Costallat LT, Bertolo MB, Coimbra IB, Borba Neto EF, Bonfá E, Tavares JC, Brenol, Xavier R, Mucenic T, Cavalcanti Fde S, Duarte AL, Marques CD, Da Silva NA, de O e Silva AC, Pacheco TF, Molina-Restrepo JF, Molina-López J, Iglesias-Gamarra A, Iglesias-Rodríguez A, Egea-Bermejo E, Guzmán-Moreno RA, Restrepo-Suárez JF, Guibert-Toledano M, Reyes-Llerena GA, Massardo L, Gareca N, Jacobelli S, Neira OJ, Guzmán LR, Garcia-Kutzbach A, Castellanos C, Cajas E, Pascual-Ramos V, Barile-Fabris LA, Miranda-Limón JM, Amigo MC, Silveira LH, De La Torre IG, Orozco-Barocio G, Estrada-Contreras ML, del Pozo MJ, Aranda Baca LE, Quezada AU, Huerta-Yáñez GF, Ac… See abstract for full author list ➔ Ramírez Gómez LA, et al. Lupus. 2008 Jun;17(6):596-604. doi: 10.1177/0961203307088006. Lupus. 2008. PMID: 18539716
113 results